Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)
04 October 2022 - 09:12PM
Edgar (US Regulatory)
Filed by AeroClean Technologies, Inc.
Pursuant to Rule 425 under the Securities Act of 1933
and deemed filed pursuant to Rule 14a-12
of the Securities Exchange Act of 1934
Subject Company: AeroClean Technologies, Inc.
Commission File No. 001-41096
Dear Molekule Customer -
Today we announced that we have signed a definitive agreement to
merge with AeroClean Technologies, Inc. (Nasdaq: AERC), a
leading air hygiene technology company. The planned merger will
unite two leading air purifier brands with a rigorous commitment to
science-based technology, and aims to expand consumer and
commercial access to clean air.
As the world grapples with an escalating climate crisis and
widespread airborne viruses, the challenge of purifying indoor air
is more urgent than ever before. Consumers, government leaders, and
business owners understand the urgency of this clean air crisis,
yet still struggle to find science-backed solutions. The proposed
merger between AeroClean and Molekule signals a new clean air
revolution. AeroClean and Molekule have set a high standard in
purifier testing, development, and performance—together, the
combined brands will seek to complement and supplement each other
to improve operational efficiency, increase educational efforts,
and expand clean air access.
The brands intend to combine executive teams, operations, and
product lines over the coming months. The merged company will be
named Molekule, Inc., and will be traded under a new Nasdaq
ticker, MKUL, upon completion of the planned merger. While this is
an exciting time for the company and customers alike, I want
to assure you that there will be no interruptions to our business.
You can still buy products on our website, your filter subscription
will operate as it always has, and our customer service team is
ready to support you in everything you need.
We thank you for your continued support of Molekule, and we look
forward to many more years supporting you in your quest to improve
YOUR indoor air quality.
Be well,
Jonathan
CEO
Important Additional Information
In connection with the proposed transaction, AeroClean intends to
file a registration statement on Form S-4 with the Securities
and Exchange Commission (the “SEC”) that will include an AeroClean
information statement and prospectus (the “information
statement/prospectus”), and will file other documents with the SEC
regarding the proposed transaction. The Form S-4 and
information statement/prospectus will contain important information
about AeroClean, Molekule, the merger and related matters.
STOCKHOLDERS ARE URGED TO CAREFULLY READ THE ENTIRE REGISTRATION
STATEMENT AND INFORMATION STATEMENT/ PROSPECTUS AND OTHER RELEVANT
DOCUMENTS FILED WITH THE SEC WHEN THEY BECOME AVAILABLE, BECAUSE
THEY WILL CONTAIN IMPORTANT INFORMATION. A definitive information
statement/prospectus will be sent to AeroClean’s stockholders prior
to the consummation of the proposed transaction. AeroClean
stockholders will be able to obtain the registration statement and
the information statement/prospectus from the SEC’s website or from
AeroClean’s website. These documents may also be obtained free of
charge from AeroClean by requesting them by mail at 10455 Riverside
Drive, Suite 100, Palm Beach Gardens, FL 33410.
No Offer or Solicitation
This communication shall not constitute an offer to sell or the
solicitation of an offer to sell or the solicitation of an offer to
buy any securities, nor shall there be any sale of securities in
any jurisdiction in which such offer, solicitation or sale would be
unlawful prior to registration or qualification under the
securities laws of any such jurisdiction. No offer of securities
shall be made except by means of a prospectus meeting the
requirements of Section 10 of the Securities Act of 1933, as
amended, and otherwise in accordance with applicable law.
Forward-Looking Statements
This communication contains “forward-looking statements” within the
meaning of the “safe harbor” provisions of the Private Securities
Litigation Reform Act of 1995. These forward-looking statements are
based upon current beliefs and expectations of our management and
are subject to known and unknown risks and uncertainties. Words or
expressions such as “expects,” “anticipates,” “intends,” “plans,”
“believes,” “estimates,” “may,” “will,” “projects,” “could,”
“should,” “would,” “seek,” “forecast,” or other similar expressions
help identify forward-looking statements. Factors that could cause
actual events to differ include, but are not limited to:
|
● |
the risk that the transaction may
not be completed; |
|
● |
the ability to successfully combine
the businesses of AeroClean and Molekule; |
|
● |
the ability of the parties to
achieve the expected synergies and other benefits from the proposed
transaction within the expected time frames or at all; |
|
● |
the incurrence of significant
transaction and other related fees and costs; |
|
● |
the incurrence of unexpected costs,
liabilities or delays relating to the transaction; |
|
● |
the risk that the public assigns a
lower value to Molekule’s business than the value used in
negotiating the terms of the transaction; |
|
● |
the risk that the transaction may
not be accretive to AeroClean’s current stockholders; |
|
● |
the risk that the transaction may
prevent AeroClean from acting on future opportunities to enhance
stockholder value; |
|
● |
the dilutive impact of the stock
consideration which will be issued in the transaction; |
|
● |
the risk that any goodwill or
identifiable intangible assets recorded due to the transaction
could become impaired; |
|
● |
potential disruptions to the
business of the companies while the transaction is pending; |
|
● |
the risk that a closing condition
to the proposed transaction may not be satisfied; |
|
● |
the occurrence of any event, change
or other circumstances that could give rise to the termination of
the transaction; and |
|
● |
other economic, business,
competitive, and regulatory factors affecting the businesses of
AeroClean and Molekule generally, including those set forth in
AeroClean’s filings with the SEC, including in the “Risk Factors”
and “Management’s Discussion and Analysis of Financial Condition
and Results of Operations” sections of AeorClean’s latest annual
report on Form 10-K, quarterly reports on Form 10-Q,
current reports on Form 8-K, and other SEC filings. |
Forward looking statements are not guarantees of future performance
and involve risks and uncertainties, and actual results may differ
materially from those in the forward-looking statements as a result
of various factors. Although AeroClean believes that the
expectations reflected in the forward-looking statements are
reasonable based on information currently available, AeroClean
cannot assure you that the expectations will prove to have been
correct. Accordingly, you should not place undue reliance on these
forward-looking statements. In any event, these statements speak
only as of the date of this release. The parties undertake no
obligation to revise or update any of the forward-looking
statements to reflect events or circumstances after the date of
this release or to reflect new information or the occurrence of
unanticipated events.
AeroClean Technologies (NASDAQ:AERC)
Historical Stock Chart
From May 2023 to Jun 2023
AeroClean Technologies (NASDAQ:AERC)
Historical Stock Chart
From Jun 2022 to Jun 2023